{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T05:35:51Z","timestamp":1767591351698,"version":"3.48.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The prognostic utility of the red cell distribution width-to-albumin ratio (RAR) in non-muscle-invasive bladder cancer (NMIBC) has not been established. This study aimed to evaluate the associations between preoperative RAR and both recurrence-free survival (RFS) and overall survival (OS) in patients with NMIBC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective review was performed for 240 individuals with NMIBC having undergone transurethral resection of bladder tumor (TURBT) at Shijiazhuang People\u2019s Hospital from November 2013 to January 2024. Demographic characteristics, hematological parameters, pathological data, and information on instillation therapy were collected. The optimal RAR cutoff was identified by applying receiver operating characteristic (ROC) analysis. Survival curves were generated via the Kaplan\u2013Meier method. The relationships of RAR with both RFS and OS were examined using univariate and multivariate Cox proportional hazards regression models. A nomogram was created using the identified independent prognostic factors from multivariate analysis to predict RFS. The discriminative ability and clinical usefulness of the nomogram were assessed by the concordance index (C-index), the calibration plots, time-dependent ROC analysis, and decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with higher preoperative RAR showed significantly poorer RFS and OS. Multivariate analysis identified high RAR as an independent prognostic factor for both RFS (HR: 1.731, 95% CI: 1.012 - 2.959) and OS (HR: 3.425, 95% CI: 1.196 - 9.806) in NMIBC patients. Based on these findings, RAR was incorporated into a nomogram model for predicting RFS. Compared to the baseline model without RAR, the new model exhibited an improved C-index (from 0.704 to 0.728). The calibration plots demonstrated excellent consistency of the nomogram-predicted probabilities for 1-, 3-, and 5-year RFS with the actual survival rates. The time-dependent ROC analysis revealed that the areas under the curve (AUC) values for RFS predictions at 1-, 3-, and 5- years were 0.806, 0.797 and 0.806. DCA validated that the nomogram yielded a superior net benefit within threshold probability ranges of 10% to 45% when compared to traditional staging systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The findings suggest that preoperative RAR serves as a novel and independent prognostic factor for predicting RFS and OS in NMIBC cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2025.1710047","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T05:31:44Z","timestamp":1767591104000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between the red cell distribution width-to-albumin ratio and recurrence-free survival and overall survival in patients with non-muscle-invasive bladder cancer: a retrospective cohort study"],"prefix":"10.3389","volume":"15","author":[{"given":"Feifan","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiqiang","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunpeng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiongjie","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076743","article-title":"Advances in diagnosis and treatment of bladder cancer","volume":"384","author":"Lopez-Beltran","year":"2024","journal-title":"BMJ"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/life13030812","article-title":"The urinary microbiome and bladder cancer","volume":"13","author":"Heidar","year":"2023","journal-title":"Life"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003981","article-title":"Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/SUO guideline (2017; amended 2020, 2024)","volume":"212","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2458211","article-title":"Identification of multicohort-based predictive signature for NMIBC recurrence reveals SDCBP as a novel oncogene in bladder cancer","volume":"57","author":"Zhang","year":"2025","journal-title":"Ann Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3109\/10408363.2014.992064","article-title":"Red blood cell distribution width: A simple parameter with multiple clinical applications","volume":"52","author":"Salvagno","year":"2015","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1529533","article-title":"Association between the red blood cell distribution width-albumin ratio and cardiovascular diseases","volume":"12","author":"Liu","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60030391","article-title":"Red cell distribution width as a predictor of survival in patients with hepatocellular carcinoma","volume":"60","author":"Vidili","year":"2024","journal-title":"Med (Mex)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6036","article-title":"Prognostic significance of increased preoperative red cell distribution width (RDW) and changes in RDW for colorectal cancer","volume":"12","author":"Lu","year":"2023","journal-title":"Cancer Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12186017","article-title":"Serum albumin levels: A biomarker to be repurposed in different disease settings in clinical practice","volume":"12","author":"Gremese","year":"2023","journal-title":"J Clin Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109496","article-title":"Hemoglobin, albumin, lymphocyte, and platelet (HALP) score and cancer prognosis: A systematic review and meta-analysis of 13,110 patients","volume":"114","author":"Xu","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.103125","article-title":"The red cell distribution width to albumin ratio: A novel prognostic indicator in hepatitis B virus-related hepatocellular carcinoma","volume":"22","author":"Tan","year":"2025","journal-title":"Int J Med Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/20406207241298865","article-title":"Calculated haemorheological profile and laboratory parameters in new diagnosed multiple myeloma patients: retrospective analysis according to survival","volume":"15","author":"Carlisi","year":"2024","journal-title":"Ther Adv Hematol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.13213","article-title":"Ratio of red blood cell distribution width to albumin level and risk of mortality","volume":"7","author":"Hao","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6844","DOI":"10.1038\/s41598-024-57497-x","article-title":"Enhancing the evaluation of acute ischemic stroke risk in individuals with non-valvular atrial fibrillation by including laboratory indicators","volume":"14","author":"Hou","year":"2024","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13091552","article-title":"Evaluation of the RDW index (Red cell distribution width) in women with breast cancer treated with doxorubicin in a one-year follow-up study","volume":"13","author":"Sim\u00f5es","year":"2023","journal-title":"Diagnostics"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1609871","article-title":"Advances in the immunological microenvironment and immunotherapy of bladder cancer","volume":"16","author":"Meng","year":"2025","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"638.e15","DOI":"10.1016\/j.urolonc.2020.01.016","article-title":"Red cell distribution width predicts time to recurrence in patients with primary non\u2013muscle-invasive bladder cancer and improves the accuracy of the EORTC scoring system","volume":"38","author":"Fukuokaya","year":"2020","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094496","article-title":"Hypoalbuminemia as surrogate and culprit of infections","volume":"22","author":"Wiedermann","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1599104","article-title":"Association between red blood cell distribution width-to-albumin ratio and all-cause mortality in intracerebral hemorrhage","volume":"12","author":"Xu","year":"2025","journal-title":"Front Nutr"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/jpen.1451","article-title":"Hypoalbuminemia: pathogenesis and clinical significance","volume":"43","author":"Soeters","year":"2019","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026548","article-title":"The prognostic value of preoperative serum albumin in patients with bladder urothelial carcinoma undergoing transurethral resection of bladder tumor","volume":"100","author":"Shen","year":"2021","journal-title":"Med (Baltimore)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s40520-022-02315-5","article-title":"Red blood cell distribution width as a biomarker: the importance of age-dependent changes and other variables","volume":"35","author":"Frater","year":"2023","journal-title":"Aging Clin Exp Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2020.08.003","article-title":"Mechanisms of NLRP3 priming in inflammaging and age related diseases","volume":"55","author":"Gritsenko","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e00038","DOI":"10.1097\/IN9.0000000000000038","article-title":"Inflammaging and fatty acid oxidation in monocytes and macrophages","volume":"6","author":"Kruglov","year":"2024","journal-title":"Immunometabolism Cobham Surrey"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/13685538.2024.2310308","article-title":"The association of prealbumin, transferrin, and albumin with immunosenescence among elderly males","volume":"27","author":"Zhang","year":"2024","journal-title":"Aging Male Off J Int Soc Study Aging Male"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24423","article-title":"Red blood cell distribution width-to-albumin ratio is associated with all-cause mortality in cancer patients","volume":"36","author":"Lu","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.3748\/wjg.v30.i23.2991","article-title":"Establishing and clinically validating a machine learning model for predicting unplanned reoperation risk in colorectal cancer","volume":"30","author":"Cai","year":"2024","journal-title":"World J Gastroenterol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-022-02494-9","article-title":"Impact of previous upper\/lower abdominal surgery on pancreatic surgical outcomes and complications: a propensity score matching study","volume":"407","author":"Zheng","year":"2022","journal-title":"Langenbecks Arch Surg"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.07.027","article-title":"European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)-A summary of the 2024 guidelines update","volume":"86","author":"Gontero","year":"2024","journal-title":"Eur Urol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-025-01072-0","article-title":"Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies","author":"Wen","year":"2025","journal-title":"Nat Rev Urol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1710047\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T05:31:44Z","timestamp":1767591104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1710047\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":34,"alternative-id":["10.3389\/fonc.2025.1710047"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1710047","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"article-number":"1710047"}}